Bay City Capital LLC (Bay City Capital), established in 1997 , specializes in investments in the life sciences industry.
Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70 companies. Five of these funds are general life sciences funds, and one is a nutrition and agribusiness sector fund.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 14, 2017
Twist Bioscience
|
Series Unknown | $27M | Biotechnology | — |
Dec 23, 2014
Interleukin Genetics
|
Post-IPO Equity | $5M | Biotechnology | — |
Apr 1, 2014
Madrigal Pharmaceuticals
|
Post-IPO Equity | — | Biotechnology | — |
May 20, 2013
Interleukin Genetics
|
Post-IPO Equity | $12M | Biotechnology | — |